Gilead Sciences Inc (GILD)

66.21
+3.25(+5.16%)
After Hours
66.21
0.00(0.00%)
- Real-time Data
  • Volume:
    12,311,778
  • Day's Range:
    63.66 - 66.30
  • 52 wk Range:
    57.17 - 74.12
High dividend Yield

GILD Overview

Prev. Close
62.96
Day's Range
63.66-66.3
Revenue
27.52B
Open
63.85
52 wk Range
57.17-74.12
EPS
3.3
Volume
12,311,778
Market Cap
82.92B
Dividend (Yield)
2.92
(4.41%)
Average Volume (3m)
6,959,107
P/E Ratio
19.25
Beta
0.35
1-Year Change
-11.52%
Shares Outstanding
1,253,367,394
Next Earnings Date
Oct 27, 2022
What is your sentiment on Gilead?
or
Market is currently closed. Voting is open during market hours.

Gilead Sciences Inc News

Welcome to Your News Upgrade

Be the First to Know and Act on Market Moving News.

Welcome to Your News Upgrade

Gilead Sciences Inc Analysis

Gilead Sciences Inc Company Profile

Gilead Sciences Inc Company Profile

Employees
14400

Gilead Sciences, Inc. is a biopharmaceutical company. The Company is focused on the discovery, development and commercialization of medicine to prevent and treat diseases, including human immunodeficiency virus (HIV), viral hepatitis and cancer. The Company’s products for HIV/AIDS patients include Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/Eviplera, Stribild, and Atripla. Its COVID-19 product is Veklury. The products for liver diseases includes Epclusa, Harvoni, Vosevi, Vemlidy, and Viread. The products under hematology/oncology/cell therapy include Yescarta, Tecartus, Trodelvy, and Zydelig. The other products include Letairis (ambrisentan), Ranexa (ranolazine), Cayston, Jyseleca, and AmBisome (amphotericin B liposome for injection). The Company also sells and distributes generic versions of Epclusa and Harvoni in the United States. It sells and distributes its products in the United States through the wholesale channel. It operates in more than 35 countries worldwide.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyStrong BuyStrong BuyStrong BuyBuy
Technical IndicatorsStrong BuyStrong BuyStrong BuyStrong BuySell
SummaryStrong BuyStrong BuyStrong BuyStrong BuyNeutral
  • is it a buy right now or wait for any positive news?
    0
    • do you think Trump showing fast signs of recovery and also using Gilead medicine will cause the stock to go up?
      0
      • More fake news about Gilead to boost stocks lol
        0
        • Health canada hs approved remdesivir
          0
      • if theres a single complication its gonna crash like a plane. high risk high reward
        1
        • Exactly. Probably won't go down past 65 though where is was before all this.
          0
        • They just waiting for the results , if any step in positive direction then we will see a jump bigger than MRNA
          0
      • I hoping for a new record high
        0
        • how much gain do you guys think it will do?
          0
          • This one is gonna rocket!!
            0
            • FDA coming
              0
              • sponsored by Republicans. lol
                0
                • More fake news just wait😷
                  0